Medical Cleanroom Industry Articles

Amcor to expand healthcare packaging cleanrooms in Ireland

Through this investment, the Sligo site will feature Class 7 cleanroom manufacturing environments and state-of-the art thermoforming operations, fully certified to ISO 13485 standards and meeting the highest regulatory requirements.

Celerion Expands Early Phase Clinical Pharmacology Units

Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced completion of additions to its research capacity and services

On Demand Pharmaceuticals Commissions State-of-the-Art, cGMP Medicine Manufacturing Facility

The CGMP facility represents a critical first step in a new era of drug manufacturing aimed at strengthening domestic supply chain resiliency

AllCells Announces First to Market Launch of In Stock GMP-Compliant Cryopreserved Leukopaks

Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP-compliant Cryopreserved Leukopaks significantly decrease lead time

Berry Global Unveils the United States’ First Comprehensive, Commercial-Scale Clean Room for Nine-Layer Blown Film Manufacturing

Berry Global Unveils the United States’ First Comprehensive, Commercial-Scale Clean Room for Nine-Layer Blown Film Manufacturing

The ISO 7 class clean room can produce nine-layer blown film. The new installation fully encloses commercial-scale production of Berry’s proprietary nine-layer blown film from extrusion to packaging, a first in the United States. The addition further enhances Berry’s ability to supply more sensitive applications such as sterile intravenous solution bags, pharmaceutical packaging, medical equipment manufacturing, and microchip packaging.

read more
BrainStorm Increases Commercial Manufacturing Capacity

BrainStorm Increases Commercial Manufacturing Capacity

BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, announced today that is has received Good Manufacturing Practice (GMP) approval from the Israel Ministry of Health for three state-of-the-art cleanrooms…

read more
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility

WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility

WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has received the License of Manufacturing Permit from German health authorities for its drug product facility (DP7) in Leverkusen, Germany. The permit successfully demonstrates for the first time that Premier Quality together with Record Speed WuXi Biologics consistently delivered in China can also be applied in global countries.

read more
Precision Cleanrooms New York City Office Grand Opening

Precision Cleanrooms New York City Office Grand Opening

As New York City begins its early phases of reopening since the onset of the pandemic, cleanroom design and construction services firm Precision Cleanrooms makes its claim in the Big Apple with its first New York City office in the company’s 32-year history. Located in Union Square at 41 East 11th Street, Precision Cleanrooms’ New York office will serve customers in greater New York and the extended Northeastern United States, providing turnkey cleanroom solutions and services for many industries including: pharmaceutical, biotech, medical device, and microelectronics industries.

read more
PAJUNK Celebrates New U.S. Headquarters

PAJUNK Celebrates New U.S. Headquarters

PAJUNK, a leading global provider of medical devices, moved into its new headquarters, located in Alpharetta, GA, just north of Atlanta. The 50,000 square foot building houses new office space, a state-of-the-art clean room for manufacturing procedural trays, and a 30,000 square foot warehouse. The increased space is designed to keep up with growing demands while providing best-in-class customer service.

read more
Novo Holdings Leads $200M investment in Esco Lifesciences Group

Novo Holdings Leads $200M investment in Esco Lifesciences Group

Novo Holdings today announced that it has co-led with Vivo Capital the over-subscribed US$200 million Series A and Crossover round in Esco Lifesciences Group (“Esco”), a leading provider of life sciences tools and services. The financing will enable Esco to strengthen its position through organic and external growth and transformation, as well as invest in China, thus addressing some of the most dynamic market segments and geographies. Other investors include two Asian sovereign wealth funds and Singapore-based global investor, EDBI.

read more